Condition: Chronic Obstructive Pulmonary Disease · Sponsor: Sanofi
LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compared with placebo on airway inflammation, resistance, and remodeling including mucus plugging and its association with improvement on lung function, exacerbations, and quality of life improvement in participants aged 40 years of age up to 85 years of age (inclusive). Study details include: The study duration will be up to 40 weeks. The treatment duration will be up to 24 weeks. The number of visits will be 9.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · contact-us@sanofi.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham - School of Medicine- Site Number : 8400003 | Birmingham, Alabama, United States | Recruiting |
| Finlay Medical Research- Site Number : 8400010 | Miami, Florida, United States | Recruiting |
| Private Practice - Dr. David Kavtaradze- Site Number : 8400017 | Cordele, Georgia, United States | Recruiting |
| University of Kansas Medical Center- Site Number : 8400005 | Kansas City, Kansas, United States | Recruiting |
| Johns Hopkins Bayview Medical Center- Site Number : 8400009 | Baltimore, Maryland, United States | Recruiting |
| Brigham & Women's Hospital- Site Number : 8400014 | Boston, Massachusetts, United States | Recruiting |
| American Health Research - Charlotte- Site Number : 8400013 | Charlotte, North Carolina, United States | Recruiting |
| Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004 | Winston-Salem, North Carolina, United States | Recruiting |
| Clinical Research Associates of Central Pennsylvania- Site Number : 8400002 | DuBois, Pennsylvania, United States | Recruiting |
| REX Clinical Trials - Beaumont- Site Number : 8400011 | Beaumont, Texas, United States | Recruiting |
| Investigational Site Number : 0320001 | San Miguel de Tucumán, Tucumán Province, Argentina | Recruiting |
| Investigational Site Number : 0320002 | Buenos Aires, Argentina | Recruiting |
+ 56 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07053423